Biotechnology company PharmaZen is in receivership, with the bank-initiated move prompting a clap-back from the company’s board.
Advertisement
Dairy Meat Processed Produce Seafood Beverage
Corporate & Results People Events Awards Campaigns
Data Research Prices Technology Video & Audio
Government Regulation Politics Education & Training Employment
Supermarkets Hospitality Export Health Sustainability Environment
China Australia Asia Pacific North America South America Europe Middle East & Africa
About Contact Newsletters
Advertise Sponsor Subscribe
NZ Media Council Privacy Policy Terms & Conditions
© 2026 Business Media Network Ltd Tourism Ticker | Property Ticker Website by Webstudio